NeuroendocrinologyHumansPancreatic NeoplasmsBiomarkersTumorNeuroendocrine Tumors
<italic>PDIA5</italic> and <italic>ARFIP1</italic> as Immunogenetic Biomarkers and Therapeutic Targets in Pancreatic Neuroendocrine Neoplasms: A Multi-Omics Study Integrating MR, Gene Expression Microarray, and Single-Cell Transcriptomics.
Huimin Guo, Guiwen Zheng, Shuzhan Yao, Qiang Jia, Jian Tan, Zhaowei Meng
Published: 202510.1159/000548070
Abstract
INTRODUCTION: Pancreatic neuroendocrine neoplasms (PanNENs) are characterized by significant clinical heterogeneity and limited therapeutic options, particularly in metastatic or recurrent cases. Identifying actionable molecular targets and biomarker…
Preview only. Read the full abstract at the source